Compare DSWL & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSWL | BHST |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | Macau | Canada |
| Employees | N/A | N/A |
| Industry | Plastic Products | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 41.3M |
| IPO Year | 2000 | 2017 |
| Metric | DSWL | BHST |
|---|---|---|
| Price | $3.15 | $1.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 10.1K | ★ 32.8K |
| Earning Date | 06-17-2026 | 05-15-2026 |
| Dividend Yield | ★ 5.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $146.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.84 | $1.45 |
| 52 Week High | $4.06 | $12.80 |
| Indicator | DSWL | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 47.77 | 24.27 |
| Support Level | $2.98 | N/A |
| Resistance Level | $3.17 | $2.05 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 33.37 | 6.36 |
Deswell Industries Inc comprise the manufacturing and sales of injection-molded plastic parts and components and electronic products assembling. The manufacturing activities are subcontracted to operating in the Macao Special Administrative Region (Macao) of the PRC. It produce a wide variety of plastic parts and components that are used in the manufacture of consumer and industrial products, using different plastic injection technologies, such as film injection, integrated injection and insert injection. It has two segments: plastic injection molding and electronic products assembling. It has generates majority of profit from Electronic Segment. It has presence in China, United States, Europe, Hong Kong, United Kingdom, Canada, and Others of which majority of sales is from China.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.